Definitive Agreement
-
Financial
Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.
Acquisition intended to expand neuromodulation portfolio to provide more treatment options for people living with chronic low back pain MARLBOROUGH,…
Read More » -
Spine
Centinel Spine® Continues Drive to Number One Global Market Position in Total Disc Replacement through Divestment of its Spine Fusion Business to Silony Medical
The transaction includes the sale of all cervical and lumbar fusion products, including the STALIF® technology platform. Divestment of the fusion portfolio…
Read More » -
Biologics
Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
PITTSBURGH & FLAGSTAFF, Ariz., July 27, 2023 – OrthoSpineNews – Carmell Therapeutics Corporation (Nasdaq: CTCX) (“Carmell”), a regenerative medicine company…
Read More » -
Financial
Spinal Stabilization Technologies, LLC, a Leading Developer and Manufacturer of Spinal Medical Devices, to be Publicly Listed through a Proposed Business Combination with BlueRiver Acquisition Corp.
Spinal Stabilization Technologies is a pioneer in developing minimally invasive surgical treatments for specific types of lower back pain. It…
Read More » -
Biologics
HippoFi is Finalizing Definitive Agreements to Join Forces with Industry Giant to Revolutionize the Spinal Biologic Market
IRVINE, CA., July 25, 2023 /OrthoSpineNews/ – HippoFi, Inc. (OTCPK:ORHB) – HippoFi, a healthcare technology and innovation firm focused on…
Read More » -
Biologics
BioRestorative Therapies Announces $2.1 Million Registered Direct Offering
MELVILLE, N.Y., July 11, 2023 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX), a clinical stage…
Read More » -
Financial
Conformis Announces Definitive Agreement to be Acquired by restor3d for a Purchase Price of $2.27 Per Share in Cash
Combination creates a leading personalized 3D-printed orthopedic medical device company DURHAM, N.C. and BILLERICA, Mass., June 23, 2023 (GLOBE NEWSWIRE)…
Read More » -
Financial
Surgalign Enters Into Definitive Agreement to Sell Global Hardware and Biologics Business Through a Structured Sale Process Under Chapter 11 of the U.S. Bankruptcy Code
DEERFIELD, Ill., June 20, 2023 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc., (NASDAQ: SRGA) (“Surgalign” or the “Company”) a global medical…
Read More » -
Recon
Zimmer Biomet Announces Acquisition of OSSIS
SINGAPORE, May 1, 2023 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced it…
Read More » -
Extremities
Enovis to Acquire Novastep
Strengthens Foot and Ankle Portfolio with Leading Minimally Invasive Surgery (MIS) Platform, including MIS Bunion System and Furthers Global Expansion…
Read More » -
Spine
Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million
Expands Xtant’s Product Offering with the Leading PMA-Approved Intralaminar Stabilization Device Strengthens Surgalign’s Balance Sheet as it Embarks on its Digital…
Read More » -
Financial
Globus Medical and NuVasive to Combine in All-Stock Transaction to Create Innovative Global Musculoskeletal Company Focused on Patient Care
Capitalizes on complementary global commercial organizations and accelerates Globus Medical’s and NuVasive’s globalization strategies to increase customer reach and deepen…
Read More » -
Financial
Zimmer Biomet to Acquire Embody, Inc.
Deal Strengthens Zimmer Biomet’s Growing Sports Medicine Portfolio and Supports Continued Company Transformation WARSAW, Ind., Jan. 5, 2023 /PRNewswire/ — Zimmer Biomet…
Read More » -
Spine
Orthofix and SeaSpine to Combine in Merger of Equals to Create Leading Global Spine and Orthopedics Company
Highly complementary spine and orthopedics portfoliosOne of the industry’s broadest biologics and regenerative technology offeringsDifferentiated and synergistic enabling technologiesMeaningful cross-selling…
Read More » -
Financial
InVivo Therapeutics Announces $9 Million Registered Direct and Private Placement Offerings, Priced At-the-Market Under Nasdaq Rules
October 7, 2022 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with…
Read More »